Gabelli & Co Investment Advisers’s Medicines Co MDCO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-343,710	Closed	-$29.2M	–	230
2019 Q4	$29.2M	Buy	+343,710	New	+$22.9M	3.38%	9

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Gabelli & Co Investment Advisers's MDCO Position: Q1 2020 in Review

Gabelli & Co Investment Advisers sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 343,710 shares — an estimated $29.2M sold.

Gabelli & Co Investment Advisers first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $29.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Gabelli & Co Investment Advisers reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 343,710 Medicines Co shares in Q1 2020, an estimated $29.2M.
Gabelli & Co Investment Advisers first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Medicines Co position peaked at $29.2M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2020, filed 14 May 2020.